We plan to extend our previous studies on mechanisms underlying regulation of Alpha1aARs, by investigating the scaffolding protein spinophilin in Alpha1aAR signaling/ trafficking. Preliminary data demonstrate spinophilin interacts with aiaARs with higher affinity than Alpha1bARs We also plan to extend our studies by studying matnx metalloproteases (MMPs) in mediating Alpha1aAR signaling via EGFR transactivation compared with Alpha1bARs. Here we have a powerful new tool, a.naturally occurnng human 3rd intracellular loop Alpha1a-SNP G247R, which in our preliminary data provides differential activation of specific MMP subtypes Finally, while aims 1 &2 explore targeted, clinically relevant signaling proteins/ pathways, we recognize the importance of exploring novel binding partners Therefore our last specific aim will use Tandem-Affinity Purification combined with mass spectrometry to identify novel multi-protein complexes (the broader Alpha1aAR signalosome) important in Alpha1aAR signaling/ trafficking.- Unique resources and collaborators available at the Univ of WA make this approach both feasible and quantitative.
AIM 1 : Targeted examination of the scaffold protein spinophilin in Alpha1aAR signaling and trafficking Hypothesis. Spinophilin binding to the Alpha1gAR 3 rd loop mediates distinct subtype signaling trafficking 1 a Characterize spinophilin/ Alpha1aAR 3rd loop binding (co-immunoprecipitation assays, structure/function ? analysisryeast 2-hybrid effects) &altered signaling pathways-(specific inhibitors,-siRNAs) 1 b Examine role of spinophilin in Alpha1aAR constitutive &agonist-induced trafficking , 1 c. Compare Alpha1aAR sphinophilin-modulated signaling effects with OibAR and Alpha1aAR 3rd loop SNP G247R AIIM 2: Investigate role of IMMPs in EGFR transactivation in Alpha1aAR signaling Hypothesis: Differential activation of specific MMPs by Alpha1AR subtypes mediates distinct signaling /trafficking 2 a Characterize role of MMPs in EGFR transactivation for differential Alpha1aAR signaling (WT vs G247SNP) 2 b Examine gene expression arrays for OigAR WT ve'rsus G247 SNP &aib to identify specific MMPs involved (confirm using specific transactivation assays and inhibitors) AIM 3'Utilize genomic/proteomic approaches to identify broader Alpha1aAR signalosome Hypothesis. Proteomics can be used to identify novel proteins in broader multi-protein complexes (signalosome) important in unique Alpha1gAR signaling and cellular trafficking 3.a Create tandem-affinity purification (TAP)-tag constructs for OigAR, OibAR Oia-SNP, establish cell lines 3.b Use proteomics-tandem reverse-phase liquid chromatography mass spectrometry (LC-MS/MS, LTQFT) technology to identify multi-protein complexes important in Alpha1a versus Alpha1bAR signaling/trafficking 3 c Perturb system (agonist/antagonist drugs, G247R Alpha1-SNP) to identify differential signalosomes' 3 d Compare Alpha1aAR signalosomes in 4 cell lines commonly used in Alpha1aAR studies (rat/human with different surface versus intracellular receptor expression to identify key proteins modulating Alpha1aAR trafficking

Public Health Relevance

Alpha1aARs are important in many diseases such as hypertension, blood vessel repair, prostate and myocardial hypertrophy, and myocardial ischemia Understanding how these receptors are regulated, particularly in their unique cellular environments, provides new understanding and drug targets for disease treatment

Agency
National Institute of Health (NIH)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL049103-21
Application #
8663941
Study Section
No Study Section (in-house review) (NSS)
Program Officer
Wong, Renee P
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Iowa
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kleine-Brueggeney, Maren; Gradinaru, Irina; Babaeva, Ekaterina et al. (2014) Alpha1a-adrenoceptor genetic variant induces cardiomyoblast-to-fibroblast-like cell transition via distinct signaling pathways. Cell Signal 26:1985-97
Lei, Beilei; Schwinn, Debra A; Morris, Daniel P (2013) Stimulation of *1a adrenergic receptors induces cellular proliferation or antiproliferative hypertrophy dependent solely on agonist concentration. PLoS One 8:e72430
Landau, Ruth; Schwinn, Debra (2013) Genotyping without phenotyping: does it really matter? Anesth Analg 116:8-10
Schwinn, D A (2011) Genetics and patient outcome after cardiac surgery: unravelling translational findings. Br J Anaesth 107:839-41
von Homeyer, Peter; Schwinn, Debra A (2011) Pharmacogenomics of ?-adrenergic receptor physiology and response to ?-blockade. Anesth Analg 113:1305-18
Oganesian, Anush; Yarov-Yarovoy, Vladimir; Parks, William C et al. (2011) Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway. Proc Natl Acad Sci U S A 108:19796-801
Lei, Beilei; Morris, Daniel P; Smith, Michael P et al. (2009) Lipid rafts constrain basal alpha(1A)-adrenergic receptor signaling by maintaining receptor in an inactive conformation. Cell Signal 21:1532-9
Turer, Aslan T; Schwinn, Debra A (2008) Understanding the transition to acute illness: the promise of perioperative genomics. J Cardiovasc Transl Res 1:171-3
Morris, Daniel P; Lei, Beilei; Wu, Yue-Xuan et al. (2008) The alpha1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J Biol Chem 283:2973-85
Stafford-Smith, Mark; Bartz, Raquel; Wilson, Katrina et al. (2007) Alpha-adrenergic mRNA subtype expression in the human nasal turbinate. Can J Anaesth 54:549-55

Showing the most recent 10 out of 35 publications